Report Detail
Global Guaifenesin (API) Market Growth 2019-2024
- RnM2887051 |
- 06 February, 2019 |
- Global |
- 162 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
The global average price of Guaifenesin (API) is in the decreasing trend, from 8.62 USD/Kg in 2012 to 7.61 USD/Kg in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Guaifenesin (API) includes 98%-99% Guaifenesin and >99% Guaifenesin, and the proportion of >99% Guaifenesin is about 74%, and the proportion is in increasing trend from 2012 to 2016.
Guaifenesin (API) is mainly used in Pharmaceuticals industry. The proportion of Guaifenesin (API) used in Pharmaceuticals industry is about 92%.
According to this study, over the next five years the Guaifenesin (API) market will register a 0.6% CAGR in terms of revenue, the global market size will reach US$ 58 million by 2024, from US$ 56 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Guaifenesin (API) business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Guaifenesin (API) market by product type, application, key manufacturers and key regions and countries.
This study considers the Guaifenesin (API) value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
98%-99%
>99%
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Pharmaceuticals
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Granules
Synthokem Labs
Haizhou Pharma
Yuan Cheng Group
Stellar Chemical
Biesterfeld
Seven Star Pharma
Camlin Fine Science
Gennex Lab
Iwaki Seiyaku
Pan Drugs
Delta Synthetic
Smart Pharm
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Guaifenesin (API) consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Guaifenesin (API) market by identifying its various subsegments.
Focuses on the key global Guaifenesin (API) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Guaifenesin (API) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Guaifenesin (API) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Guaifenesin (API) Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Guaifenesin (API) Consumption 2014-2024
- 2.1.2 Guaifenesin (API) Consumption CAGR by Region
- 2.2 Guaifenesin (API) Segment by Type
- 2.2.1 98%-99%
- 2.2.2 >99%
- 2.3 Guaifenesin (API) Consumption by Type
- 2.3.1 Global Guaifenesin (API) Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Guaifenesin (API) Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Guaifenesin (API) Sale Price by Type (2014-2019)
- 2.4 Guaifenesin (API) Segment by Application
- 2.4.1 Pharmaceuticals
- 2.4.2 Others
- 2.5 Guaifenesin (API) Consumption by Application
- 2.5.1 Global Guaifenesin (API) Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Guaifenesin (API) Value and Market Share by Application (2014-2019)
- 2.5.3 Global Guaifenesin (API) Sale Price by Application (2014-2019)
3 Global Guaifenesin (API) by Players
- 3.1 Global Guaifenesin (API) Sales Market Share by Players
- 3.1.1 Global Guaifenesin (API) Sales by Players (2017-2019)
- 3.1.2 Global Guaifenesin (API) Sales Market Share by Players (2017-2019)
- 3.2 Global Guaifenesin (API) Revenue Market Share by Players
- 3.2.1 Global Guaifenesin (API) Revenue by Players (2017-2019)
- 3.2.2 Global Guaifenesin (API) Revenue Market Share by Players (2017-2019)
- 3.3 Global Guaifenesin (API) Sale Price by Players
- 3.4 Global Guaifenesin (API) Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Guaifenesin (API) Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Guaifenesin (API) Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Guaifenesin (API) by Regions
- 4.1 Guaifenesin (API) by Regions
- 4.1.1 Global Guaifenesin (API) Consumption by Regions
- 4.1.2 Global Guaifenesin (API) Value by Regions
- 4.2 Americas Guaifenesin (API) Consumption Growth
- 4.3 APAC Guaifenesin (API) Consumption Growth
- 4.4 Europe Guaifenesin (API) Consumption Growth
- 4.5 Middle East & Africa Guaifenesin (API) Consumption Growth
5 Americas
- 5.1 Americas Guaifenesin (API) Consumption by Countries
- 5.1.1 Americas Guaifenesin (API) Consumption by Countries (2014-2019)
- 5.1.2 Americas Guaifenesin (API) Value by Countries (2014-2019)
- 5.2 Americas Guaifenesin (API) Consumption by Type
- 5.3 Americas Guaifenesin (API) Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Guaifenesin (API) Consumption by Countries
- 6.1.1 APAC Guaifenesin (API) Consumption by Countries (2014-2019)
- 6.1.2 APAC Guaifenesin (API) Value by Countries (2014-2019)
- 6.2 APAC Guaifenesin (API) Consumption by Type
- 6.3 APAC Guaifenesin (API) Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Guaifenesin (API) by Countries
- 7.1.1 Europe Guaifenesin (API) Consumption by Countries (2014-2019)
- 7.1.2 Europe Guaifenesin (API) Value by Countries (2014-2019)
- 7.2 Europe Guaifenesin (API) Consumption by Type
- 7.3 Europe Guaifenesin (API) Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Guaifenesin (API) by Countries
- 8.1.1 Middle East & Africa Guaifenesin (API) Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Guaifenesin (API) Value by Countries (2014-2019)
- 8.2 Middle East & Africa Guaifenesin (API) Consumption by Type
- 8.3 Middle East & Africa Guaifenesin (API) Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Guaifenesin (API) Distributors
- 10.3 Guaifenesin (API) Customer
11 Global Guaifenesin (API) Market Forecast
- 11.1 Global Guaifenesin (API) Consumption Forecast (2019-2024)
- 11.2 Global Guaifenesin (API) Forecast by Regions
- 11.2.1 Global Guaifenesin (API) Forecast by Regions (2019-2024)
- 11.2.2 Global Guaifenesin (API) Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Guaifenesin (API) Forecast by Type
- 11.8 Global Guaifenesin (API) Forecast by Application
12 Key Players Analysis
- 12.1 Granules
- 12.1.1 Company Details
- 12.1.2 Guaifenesin (API) Product Offered
- 12.1.3 Granules Guaifenesin (API) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Granules News
- 12.2 Synthokem Labs
- 12.2.1 Company Details
- 12.2.2 Guaifenesin (API) Product Offered
- 12.2.3 Synthokem Labs Guaifenesin (API) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Synthokem Labs News
- 12.3 Haizhou Pharma
- 12.3.1 Company Details
- 12.3.2 Guaifenesin (API) Product Offered
- 12.3.3 Haizhou Pharma Guaifenesin (API) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Haizhou Pharma News
- 12.4 Yuan Cheng Group
- 12.4.1 Company Details
- 12.4.2 Guaifenesin (API) Product Offered
- 12.4.3 Yuan Cheng Group Guaifenesin (API) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Yuan Cheng Group News
- 12.5 Stellar Chemical
- 12.5.1 Company Details
- 12.5.2 Guaifenesin (API) Product Offered
- 12.5.3 Stellar Chemical Guaifenesin (API) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Stellar Chemical News
- 12.6 Biesterfeld
- 12.6.1 Company Details
- 12.6.2 Guaifenesin (API) Product Offered
- 12.6.3 Biesterfeld Guaifenesin (API) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Biesterfeld News
- 12.7 Seven Star Pharma
- 12.7.1 Company Details
- 12.7.2 Guaifenesin (API) Product Offered
- 12.7.3 Seven Star Pharma Guaifenesin (API) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Seven Star Pharma News
- 12.8 Camlin Fine Science
- 12.8.1 Company Details
- 12.8.2 Guaifenesin (API) Product Offered
- 12.8.3 Camlin Fine Science Guaifenesin (API) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Camlin Fine Science News
- 12.9 Gennex Lab
- 12.9.1 Company Details
- 12.9.2 Guaifenesin (API) Product Offered
- 12.9.3 Gennex Lab Guaifenesin (API) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Gennex Lab News
- 12.10 Iwaki Seiyaku
- 12.10.1 Company Details
- 12.10.2 Guaifenesin (API) Product Offered
- 12.10.3 Iwaki Seiyaku Guaifenesin (API) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Iwaki Seiyaku News
- 12.11 Pan Drugs
- 12.12 Delta Synthetic
- 12.13 Smart Pharm
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Guaifenesin (API) . Industry analysis & Market Report on Guaifenesin (API) is a syndicated market report, published as Global Guaifenesin (API) Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Guaifenesin (API) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
